Literature DB >> 6318197

Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences.

P L Wood.   

Abstract

Biochemical measurements of DOPAC, HVA, DA and 3-MT allow the assessment of both DA metabolism in nerve endings and DA release into the synaptic cleft. Using these biochemical indices of DA neuronal activity, we have examined the actions of mu, delta and kappa opiate receptor agonists on the nigrostriatal pathway. These studies indicate that delta and mu2 isoreceptors regulate activity in the nigrostriatal pathway of the rat, mouse, gerbil and hamster. In general, increased DA metabolism is observed; however, increased DA release is only evident in pathways devoid of a presynaptic clamping action. As indicated with enkephalinase inhibitors, these enkephalinergic inputs to dopaminergic neurons possess a phasic ongoing activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318197     DOI: 10.1016/0196-9781(83)90003-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  20 in total

1.  Effects of dopaminergic agents on alcohol consumption by rats in a limited access paradigm.

Authors:  M A Linseman
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 2.  Interaction of Cannabis Use and Aging: From Molecule to Mind.

Authors:  Hye Bin Yoo; Jennifer DiMuzio; Francesca M Filbey
Journal:  J Dual Diagn       Date:  2019-09-30

3.  Self-administered heroin and cocaine combinations in the rat: additive reinforcing effects-supra-additive effects on nucleus accumbens extracellular dopamine.

Authors:  James E Smith; Conchita Co; Michael D Coller; Scott E Hemby; Thomas J Martin
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

4.  Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines.

Authors:  Y Masukawa; T Suzuki; M Misawa
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole.

Authors:  M Derrien; C Durieux; B P Roques
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

6.  Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.

Authors:  M R Zarrindast; A Jamshidzadeh
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

7.  Antagonism of the nicotine-induced changes of the striatal dopamine metabolism in mice by mecamylamine and pempidine.

Authors:  H Haikala; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

8.  Glutamate-evoked release of endogenous brain dopamine: inhibition by an excitatory amino acid antagonist and an enkephalin analogue.

Authors:  K Jhamandas; M Marien
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

9.  Effects of naloxone-precipitated withdrawal after a single dose of morphine on catecholamine concentrations in guinea-pig brain.

Authors:  P J Brent; L A Chahl
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

10.  Lack of evidence for an involvement of nucleus accumbens dopamine D1 receptors in the initiation of heroin self-administration in the rat.

Authors:  M A Gerrits; N F Ramsey; G Wolterink; J M van Ree
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.